Here are six things to know:
1. Biotronic is a provider of intraoperative neurophysiological monitoring services. The company provides real-time remote monitoring through proprietary software and a secure, virtual network.
2. The acquisition aims to enhance NuVasive’s spine service line offerings through improved surgical monitoring and oversight capabilities.
3. Following the close of the transaction, NuVasive plans to combine the service offerings of Biotronic with its subsidiary, Impulse Monitoring, to create NuVasive Clinical Services.
4. Both companies’ board of directors have unanimously approved the transaction.
5. NuVasive expects the transaction to be immediately accretive to its non-GAAP earnings-per-share in 2016 and significantly accretive in 2017 and beyond.
6. The transaction is expected to close in July 2016, subject to customary closing conditions.
More articles on devices:
Medtronic, K2M, J&J & more: 15 key notes
3 emerging trends that could impact the global spinal implants market
Global SCS market to grow to 2028: 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
